Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Growth was broad-based across segments
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Subscribe To Our Newsletter & Stay Updated